Letter: Pentazocine and neonatal withdrawal symptoms.
D005260:Female; D005984:Glutethimide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008134:Long-Term Care; D008431:Maternal-Fetal Exchange; D008691:Methadone / Q000627:therapeutic use; D010423:Pentazocine / Q000008:administration & dosage / Q000627:therapeutic use; D010424:Pentobarbital / Q000627:therapeutic use; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D005984:Glutethimide; D010424:Pentobarbital; D010423:Pentazocine; D008691:Methadone